Sapporo [Japan], October 7 (ANI): Researchers have devised a way to identify amyloid build-up in the brain, a symptom of Alzheimer's disease, using biomarkers found in blood samples.
Washington [US], October 5 (ANI): New research supports the hypothesis that Alzheimer's disease is caused by a decline in levels of a protein called amyloid-beta.
Houston [US], September 8 (ANI): A recently created agonistic antibody reduced amyloid pathology in mice with Alzheimer's disease, indicating its potential as a therapy for the condition, according to the researchers.
Daejeon [South Korea], August 4 (ANI): The US Food and Drug Administration recently approved Aduhelm, a monoclonal antibody that targets amyloid beta (A), as the first Alzheimer's disease treatment (AD). Its impact on cognitive improvement, however, is controversial.
Washington [US], August 7 (ANI): Why do some people with amyloid plaques in their brains, associated with Alzheimer's disease, show no signs of the disease, while others with the same amount of plaque have clear memory and thinking problems? Researchers looked at genetic and life course fact
Daejeon [South Korea], August 4 (ANI): Aduhelm, a monoclonal antibody that targets amyloid beta (A), was recently found by the US Food and Drug Administration as the first treatment for Alzheimer's disease (AD). However, its impact on cognitive improvement is still debatable.
Houston (Texas) [US], July 15 (ANI): According to a recent study from UTHealth Houston, the complete exchange of blood may be a novel, disease-modifying treatment for Alzheimer's disease. This treatment successfully reduced the development of amyloid plaque in mice's brains.
Daejeon [South Korea], June 22 (ANI): The number of elderly people suffering from Alzheimer's disease has increased rapidly in recent decades. For a long time, scientists believed that misfolded aggregates of amyloid-beta protein accumulated and formed plaques in the brain, leading to memory
Islamabad [Pakistan], June 10 (ANI): Former Pakistan president General Pervez Musharraf has been hospitalized for the last three weeks due to a complication of his ailment and is going through a difficult stage where recovery is not possible and organs are malfunctioning, his family said
California [US], January 28 (ANI): A team of researchers has developed a new method to screen drugs for treating Alzheimer's disease and answer why Alzheimer's drugs so far have been ineffective at curing or reversing the disease.
Washington [US], December 18 (ANI): A new study has found that the SARS-CoV-2 N-protein interacts with a neuronal protein and speeds the formation of pathological protein bundles that have been implicated in Parkinson's disease.
Washington [US], December 17 (ANI): A team of researchers have found that the SARS-CoV-2 N-protein interacts with a neuronal protein called a-synuclein and speeds the formation of amyloid fibrils, pathological protein bundles that have been implicated in Parkinson's disease.